Skip to main content
. Author manuscript; available in PMC: 2017 Oct 1.
Published in final edited form as: J Infect. 2016 Jul 9;73(4):336–345. doi: 10.1016/j.jinf.2016.07.002

Figure 2.

Figure 2

30-day survival after onset of monomicrobial BSI, by pathogen type. CRE (n=32) vs. ceftriaxone-susceptible Enterobacteriaceae (n=84; P<0.001); vs. ESBL/AmpC-producing Enterobacteriaceae (n=15; P=0.004); vs. Pseudomonas aeruginosa (n=18; P=0.16); vs. Gram-positive bacteria (n=59, P<0.001).